Key Insights

Highlights

Treatment Research

2 treatments under study, led by Mri With Ivim Dwmri

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02465723Not ApplicableWithdrawnPrimary

Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers

Showing all 1 trials

Research Network

Common Treatments

  • Mri With Ivim Dwmri1
  • Blood Draw1

Active Sponsors

  • Memorial Sloan Kettering Cancer Center1

Top Investigators

Related Conditions

  • Metastatic Disease To Soft Tissue1

Activity Timeline